Japanese regulators have given Exactech approval for its shoulder, knee and hip replacement systems, including the Novation crown cup acetabular component, Optetrak Logic CR knee system, Alteon tapered wedge stem and Equinoxe reverse shoulder systems. The company has also recorded the first clinical use of the devices in the country.
Dova Pharmaceuticals is ready for its initial public offering of approximately 4.1 million shares of common stock to fund development of its lead product candidate, avatrombopag, a platelet production stimulant for the treatment of thrombocytopenia. Dova intends to submit a US marketing application next quarter with the FDA.
Four new corn rootworm-resistant biotech products that contain a plant-incorporated protectant named SmartStax PRO have been approved by the Environmental Protection Agency. Scientists harnessed the ribonucleic acid interference technology found in SmartStax PRO, which silences the activity of a gene crucial to the survival of corn rootworms.
President Donald Trump discussed the future of agriculture and renewable fuels that will empower America's farmers during his visit to Iowa. "The president clearly understands the benefits of a healthy and robust ethanol industry, and recognizes the importance of both first-generation corn ethanol and emerging advanced biofuel technologies," said Renewable Fuels Association President and CEO Bob Dinneen.
This week, Lions Health named Area 23 the Healthcare Agency of the Year at its annual Cannes Lions International Festival of Creativity, four years after work by the agency's parent company, FCB Health, was shut out at the awards ceremony. Area 23 also received awards this year for its promotion of a technology that allows women to detect breast cancer by placing a device in their bras to search for abnormalities.
Zicam partnered with Simulmedia to improve its targeting of TV viewers during cold and flu season in order to stand out from the crowd. "As a result of using Simulmedia's proprietary technology to expose Zicam's message to more of its target consumers on TV and measure its positive impact on sales, Simulmedia has been able to satisfy this need for performance," said Dave Morgan, Simulmedia CEO.
An initial public offering of more than 17.2 million shares on the Swedish stock exchange, Nasdaq Stockholm, has brought in $57.4 million for Sweden-based Bonesupport. The company will use the proceeds to support sales expansion for its drug-eluting bone scaffolds that use the Cerament technology platform.
A private placement has brought in approximately $4.9 million for Oventus Medical, an Australian company that makes oral devices for treating snoring and obstructive sleep apnea. The company, which is still seeking to obtain about $379,000 in a second tranche placement, intends to use the proceeds for boosting working capital, as well as to support co-marketing partnerships in the US and Australia.
An offering of 8.9 million units of common stock, warrants and stock purchase warrants has pulled in $2.1 million in net proceeds for Great Basin Scientific. The money will be used for redemption of certain notes, research and development, and sales and marketing expenses, as well as to support general corporate functions.
A Zion Market Research report predicts the worldwide minimally invasive surgery market will see growth through 2024 because of an expanding aging population and the launch of narrow-band imaging endoscopes, confocal microendoscopes, HD endoscope cameras and other advanced technologies. Among the key market players are Varian Medical Systems, Medtronic, Zimmer Biomet, Teleflex, Stryker, NuVasive and Surgical Innovations.